Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
QNRX: Quoin Pharmaceuticals, Ltd. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
QNRX
The Story
QNRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-168.7%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
2.87×
Quoin Pharmaceuticals, Ltd.
QNRX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Quoin Pharmaceuticals, Ltd.
QNRX
NASDAQ
·
USD
·
Closed
$4.45
+1.14%
$4.45
+$0.05 (1.14%)
52W Range
3th
pctl
Volume
0.03×
avg
Mkt Cap
8.94M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.03×
avg
Market Cap
8.94M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings